News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ALTANA Pharma AG (AAA) Receives Approval To Market Ciclesonide Nasal Spray In The U.S.



10/26/2006 10:25:08 AM

BAD HOMBURG/KONSTANZ, GERMANY -- (MARKET WIRE) -- October 25, 2006 -- ALTANA AG (NYSE: AAA) (FRANKFURT: ALT) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for OMNARIS™ (Ciclesonide nasal spray), 200µg once-daily.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES